Insights

The Insights page consists of Insight Articles, Commentaries, C-level Q&As, Discussion Group Reports, and Survey Reports.

C-Level Q&As
Join us as we sit down with Malcom Weir (Executive Vice Chairman, Sosei Heptares) to discuss the Drug Discovery landscape and recent therapeutic innovations.
01 November 2021
Discovery Series
Commentary
Covalent inhibitors have progressed significantly since they were discovered in the 18th century and are now experiencing a resurgence.
By Oliver Picken |
12 October 2021
Target Based Discovery
Insight Article
Paul Andrews, Director of Operations and Dundee Lab Head, National Phenotypic Screening Centre (NPSC), University of Dundee
11 June 2019
Medicinal Chemistry & Drug Design
Insight Article
Sheila Connelly, Vice President, Research, Synthetic Biologies, Inc.
07 June 2018
Discovery Series
Insight Article
Daniel Zwilling, Director of CNS Discovery, Circuit Therapeutics
07 June 2018
Neuroscience Discovery
Insight Article
Daniel Zwilling, Director of CNS Discovery, Circuit Therapeutics
07 June 2018
Neuroscience Discovery
Insight Article
Ernesto Freire, Henry Walters Professor, John Hopkins University
07 June 2018
Target Based Discovery

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Stay up to date

Sign up for our monthly Editorial Newsletter to keep up with all things Drug Discovery

Submit your details to receive the monthly newsletter & to be kept up to date about relevant events, monthly discussion groups and portal membership offers. You may opt-out at any time. Please check our Privacy Policy to see how Oxford Global protects and manages your data.